Viviphi has appointed Howard McLeod to its precision medicine advisory board, and has named him senior research advisor in precision medicine. McLeod previously served in leadership positions at the H. Lee Moffitt Cancer Center's Department of Individualized Cancer Management. He also served as an endowed research chair in the state of Florida, professor at the University of South Florida, and serves as a 1000 Talent Scholar in China. Additionally, he has served on the FDA's committee on clinical pharmacology and on the National Institutes of Health's Human Genome Advisory Council.
Invitae has appointed Shelly Guyer as its CFO, effective June 12. She will also serve as the company's principal financial officer. Invitae's current CFO Lee Bendekgey will fully transition to his new role as COO. Most recently, Guyer served as CFO of Veracyte.
The American Society of Human Genetics has appointed Mona Miller as executive director. She will be responsible for representing the ASHG on a day-to-day basis, for guiding and implementing its broad agenda in consultation with the president and board, and for interacting on an ongoing basis with society committees. Miller currently serves as the deputy executive director for programs and finance at the Society for Neuroscience. She has previously served as the society's senior director of communications and public affairs, the senior officer of public affairs at the Pew Charitable Trusts, and as communications director to former Senator Barbara Mikulski.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.